New obesity drug could change weight loss treatment For India, where long-term adherence is a major challenge, a once-monthly GLP-1 therapy could improve patient acceptance and sustained obesity management, says Dr Anoop Misra, Chairman at Fortis CDOC Hospital for Diabetes and Allied Sciences
Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide 3.0 mg) are contraindicated during pregnancy according to their FDA labels
Lee SH, Gil YC, Choi YJ, et al
Common acne treatments include: Acne doesnt have to control your confidence or comfort
The FDA adverse event database has flagged 182 cases of GLP-1-associated sexual dysfunction since 2003 a weak signal [3]
Pharmacy-direct options Some patients prefer ordering from compounding pharmacies that work with their own provider rather than through a telehealth platform